LEY S. SMITH

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TITAN PHARMACEUTICALS INC

Filing Date Source Excerpt
2001-07-16 Ley S. Smith has served on our Board of Directors since July 2000.
2002-07-15 Ley S. Smith has served on the Board of Directors since July 2000. He is a member of the Executive Committee.
2003-07-14 Michael K. Hsu, Audit Committee Chair Hubert E. Huckel, Audit Committee Member Ley S. Smith, Audit Committee Member
2004-08-11 Ley S. Smith has served on our Board of Directors since July 2000.
2005-07-12 Ley S. Smith has served on our Board of Directors since July 2000.
2006-08-10 Ley S. Smith has served on our Board of Directors since July 2000. He served in various positions with The Upjohn Company and Pharmacia & Upjohn from 1958 until his retirement in November 1997.
2007-08-15 Ley S. Smith has served on our Board of Directors since July 2000. The Audit Committee (which is formed in compliance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934) consists of three directors, Ley S. Smith, M. David MacFarlane and Hubert E. Huckel. The Board of Directors has an Executive Committee, a Compensation Committee, a Nominating Committee and an Audit Committee. The Nominating Committee consists of three directors, Eurelio M. Cavalier, M. David MacFarlane and Ley S. Smith.
2008-04-03 Ley S. Smith has served on our Board of Directors since July 2000. He served in various positions with The Upjohn Company and Pharmacia & Upjohn from 1958 until his retirement in November 1997. ... Member of Executive Committee ... Member of Audit Committee ... Member of Nominating Committee ... Non-employee directors are entitled to receive a fee for each meeting attended ... During 2007, each director was granted an annual option to purchase 5,000 shares ... In addition to having their out-of-pocket expenses reimbursed, non-employee directors received $2,500 for each Board of Directors meeting attended in 2007. ... Ley S. Smith Fees Earned or Paid in Cash($): 15,000 ... Total: 35,817
2015-07-20 Ley S. Smith served in various positions with The Upjohn Company and Pharmacia & Upjohn from 1958 until his retirement in November 1997. From 1991 to 1993, he served as Vice Chairman of the Board of The Upjohn Company, and from 1993 to 1995 he was President and Chief Operating Officer of The Upjohn Company. At the time of his retirement, Mr. Smith was Executive Vice President of Pharmacia & Upjohn, and President of Pharmacia & Upjohn's U.S. Pharma Product Center. Based on Mr. Smith's management experience in the pharmaceutical industry, our Board believes that Mr. Smith has the appropriate set of skills to serve as a member of the Board.
2016-06-29 The audit committee was formed in compliance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934 (the “Exchange Act”) and currently consists of Joseph A. Akers, Ley S. Smith, M. David MacFarlane and Victor J. Bauer, each of whom meets the independence requirements and standards currently established by the Nasdaq and the SEC.

Data sourced from SEC filings. Last updated: 2026-02-03